Entain PLC
OTC:GMVHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Entain PLC
OTC:GMVHF
|
IM |
|
I
|
IWS Group Holdings Ltd
HKEX:6663
|
HK |
|
XANO Industri AB
STO:XANO B
|
SE |
|
Aethlon Medical Inc
NASDAQ:AEMD
|
US |
|
International Distributions Services PLC
LSE:IDS
|
UK |
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
AU |
|
Damodar Industries Ltd
NSE:DAMODARIND
|
IN |
|
Invex Controladora SAB De CV
BMV:INVEXA
|
MX |
|
C
|
Cemtas Celik Makina Sanayi ve Ticaret AS
IST:CEMTS.E
|
TR |
Wall Street
Price Targets
GMVHF Price Targets Summary
Entain PLC
According to Wall Street analysts, the average 1-year price target for
GMVHF
is 14.716 USD
with a low forecast of 11.276 USD and a high forecast of 17.585 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GMVHF's stock price target?
Price Target
14.716
USD
According to Wall Street analysts, the average 1-year price target for
GMVHF
is 14.716 USD
with a low forecast of 11.276 USD and a high forecast of 17.585 USD.
What is Entain PLC's Revenue forecast?
Projected CAGR
7%
For the last 9 years the
compound annual growth rate for
Entain PLC's revenue is
27%.
The projected
CAGR
for the next 3 years is
7%.
What is Entain PLC's Operating Income forecast?
Projected CAGR
25%
The
compound annual growth rate
of Entain PLC's operating income for the next 3 years is
25%.
